Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management
Chen MK, Doddamane I, Cheng DW. Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management. Current Opinion In Oncology 2010, 22: 6-10. PMID: 19844179, DOI: 10.1097/cco.0b013e3283339d5d.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsRecombinant human thyroid-stimulating hormoneHuman thyroid-stimulating hormoneMetastatic thyroid cancerThyroid-stimulating hormoneThyroid cancerThyroglobulin levelsWhole body radiation exposureThyroid hormone withdrawalThyroid remnant ablationFurther prospective studiesLong-term outcomesRate of recurrenceSurveillance of patientsThyroid cancer managementBody radiation exposureNegative predictive valueRadioiodine ablationPersistent diseaseRadioiodine treatmentRemnant ablationThyroid remnantsWithdrawal patientsPatients' qualityPatient groupProspective study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply